Spray chemo shows promise for tough stomach cancer

NCT ID NCT06313801

First seen Nov 19, 2025 · Last updated May 16, 2026 · Updated 21 times

Summary

This study compares standard chemotherapy alone versus chemotherapy plus a special procedure called PIPAC (a spray form of chemo delivered directly into the abdomen) for people with stomach cancer that has spread to the lining of the belly. About 106 adults aged 18-75 will take part. The goal is to see if adding PIPAC helps control the cancer longer and with fewer side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Research Institute of Clinical Oncology "Nizhny Novgorod Regional Clinical Oncological Dispensary", 11/1, Delovaya street, Nizhny Novgorod, 603126

    RECRUITING

    Nizhny Novgorod, 603126, Russia

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.